本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Akero Therapeutics

55.62
+2.063.85%
盘后56.580.9600+1.73%17:08 EDT
成交量:222.43万
成交额:1.22亿
市值:44.34亿
市盈率:-14.86
高:55.83
开:52.19
低:52.19
收:53.56
数据加载中...
2024/07/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/07/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/07/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/12

重要事件披露

Form 8-K - Current report
2024/05/10

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/10

重要事件披露

Form 8-K - Current report
2024/04/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/18

重要事件披露

Form 8-K - Current report
2024/03/15

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/03/06

重要事件披露

Form 8-K - Current report
2024/03/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/04

重要事件披露

Form 8-K - Current report
2024/02/29

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/02/29

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/29

重要事件披露

Form 8-K - Current report
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals